1,1'-(5-(Trifluoromethyl)-1,3-phenylene)bis(1H-imidazole)

Catalog No. :
ACDVTN380
CAS No. :
2110472-44-9
Molecular Formula :
C13H9F3N4
Molecular Weight :
278.24

IUPAC Name:1,1'-(5-(trifluoromethyl)-1,3-phenylene)bis(1H-imidazole)

1,1'-(5-(Trifluoromethyl)-1,3-phenylene)bis(1H-imidazole) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$64.00Login to see priceIn stockIn stock
1g95%$238.00Login to see priceIn stockIn stock
5g95%$1080.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,1'-(5-(Trifluoromethyl)-1,3-phenylene)bis(1H-imidazole)
IUPAC Name1,1'-(5-(trifluoromethyl)-1,3-phenylene)bis(1H-imidazole)
Molecular FormulaC13H9F3N4
Molecular Weight278.24
SMILESFC(C1=CC(N2C=CN=C2)=CC(N3C=CN=C3)=C1)(F)F
InChI KeyTXIUSTMQRBRRIO-UHFFFAOYSA-N
Synonym1,1'-(5-(trifluoromethyl)-1,3-phenylene)bis(1H-imidazole);1H-Imidazole, 1,1'-[3-(trifluoromethyl)-1,5-phenylene]bis-
CAS No.2110472-44-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACDVTN380 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAJBC918 route compound structure diagram
    ACAJBC918401-84-3 In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACDVTN380 route product structure diagram
    ACDVTN3802110472-44-9 In Stock
Inquiry

2. ACDVTN380 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACDVTN380 route product structure diagram
    ACDVTN3802110472-44-9 In Stock
Inquiry

Comments (0)